FDA OK’s Merck’s new hepatitis C drug
January 28, 2016 at 20:45 PM EST
The U.S. Food and Drug Administration approved Merck & Co.’s new treatment for hepatitis C, the latest entrant in a booming market for drugs for the viral infection — a market now dominated by Gilead Sciences Inc.
